Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661b3ea63e73acc96731eb73625b1bc2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-1101 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2015-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_979e16340a3ed7960e48bd3a2272f75a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aec671cdc9bab70647ef1573a43beb65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c49885c99e0f64451876259794a1626 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e98d7ed279ff220847bc948b727f56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1106224fcbb9ef43184ab13e67fd39dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbe404885038948fa258f30793201912 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b852669beb023fedb4bdb99ec5da20ff |
publicationDate |
2015-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015240242-A1 |
titleOfInvention |
Compositions And Methods For Inhibiting Expression Of IKK-B Gene |
abstract |
The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the IKK-B gene, comprising an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the IKK-B gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression or activation of the IKK-B gene using the pharmaceutical composition; and methods for inhibiting the expression of the IKK-B gene in a cell. |
priorityDate |
2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |